Single-cell gene networks nominate IKZF1 as an Alzheimer's disease microglial regulator.
IKZF1 is prioritized as a candidate late-disease microglial TF, supported by six convergent evidence dimensions including independent bulk replication, and low-confidence repurposing hypotheses requiring experimental validation.